Company intelligence / Profile preview

SAGES Ingenuity

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

SAGES Ingenuity is the for-profit innovation arm and subsidiary of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Established to accelerate clinical innovation, the company partners with Varia Ventures to manage the SAGES Investment Network Collaborative (SINC) Opportunity Fund. The fund strategically invests in seed to Series A startups advancing the fields of endoscopic, laparoscopic, and general surgery, as well as gastrointestinal diagnostics and therapeutics. Notable portfolio investments include Endolumik, NeXtGen Biologics, Geneoscopy, and Hypervision Surgical.

Industry: Investors

Partnerships

Varia Ventures

Beyond the preview

Go deeper on SAGES Ingenuity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SAGES Ingenuity.

Explore the full profile